Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories is currently trading at Rs. 3080.45, up by 26.10 points or 0.85% from its previous closing of Rs. 3054.35 on the BSE.

The scrip opened at Rs. 3070.00 and has touched a high and low of Rs. 3082.50 and Rs. 3052.05 respectively. So far 6,929 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 3187.20 and Rs. 3042.55 respectively. The current market cap of the company is Rs. 51,025.00 crore.

The promoters holding in the company stood at 26.37%, while Institutions and Non-Institutions held 41.16% and 15.64% respectively.

Dr. Reddy’s Laboratories has forayed into the Colombian market with its portfolio of high quality and affordable medicines for cancer drugs.

The Hyderabad-based firm operates in all major markets including the US, Russia, CIS countries and Europe with a workforce of above 20,000 employees. Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.